• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

Viatris And Oyster Point – Mylan All Over Again? (NASDAQ:OYST)

November 17, 2022 admin 0

gremlin Introduction I have covered Viatris (NASDAQ:VTRS) on several occasions in the past. My original investment case was outlined back in 2021 when the company still traded at around $14. On a total return basis, […]

Stock News

3 Reasons Why Clearway Energy Is One Of My Top Holdings (NYSE:CWEN)

November 17, 2022 admin 0

yangphoto Clearway Energy Inc. (NYSE:CWEN, NYSE:CWEN.A), owner of a portfolio of operational renewable energy assets, is one of my favorite dividend growth stocks. CWEN’s parent company and sponsor, the privately owned Clearway Energy Group (“CEG”), […]

Stock News

Target Q3 Earnings: A Rough Quarter, Signs Of More Pain To Come (NYSE:TGT)

November 17, 2022 admin 0

JHVEPhoto November 16th was not a particularly pleasant day for shareholders of retail giant Target (NYSE:TGT). Despite reporting revenue figures for the third quarter of its 2022 fiscal year that exceeded expectations set by analysts, […]

Posts navigation

« 1 … 3,995 3,996 3,997 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Southern Co (SO) CEO Thomas Fanning on Q2 2022 Results – Earnings Call Transcript
    July 28, 2022 0
  • Crude Oil Perseveres
    June 7, 2022 0
  • As Russia cuts gas, German industry grapples with painful choices By Reuters
    June 23, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.